A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users

NCT03158025 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorders

Interventions

DRUG: Zolpidem tablets
DRUG: Suvorexant tablets, over-encapsulated
DRUG: Lemborexant tablets
DRUG: Placebo lemborexant
DRUG: Placebo zolpidem
DRUG: Placebo suvorexant

Sponsor

Eisai Inc.

Collaborators

[object Object]